Poolbeg Pharma PLC (AIM:POLB)
London · Delayed Price · Currency is GBP · Price in GBX 7.90
+0.30 (4.00%)
Jun 16, 2026, 11:08 AM GMT
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 53.59 million as of June 16, 2026. Its market cap has increased by 234.92% in one year.
Market Cap
53.59M
Enterprise Value
45.87M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
7.90
Market Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 53.59M, a decrease of -0.30%. That is a compound annual growth rate of -0.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 54.29M | 94.68% |
| Dec 31, 2025 | 27.89M | -21.44% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
| Jul 19, 2021 | 53.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Faron Pharmaceuticals Oy | 91.30M |
| Bioventix | 84.90M |
| 4basebio | 81.58M |
| Ondine Biomedical | 67.54M |
| hVIVO | 58.05M |
| Hemogenyx Pharmaceuticals | 56.13M |
| Sareum Holdings | 31.87M |
| ImmuPharma | 30.01M |